I still remember the morning of August 2, 2024. I was sitting in our weekly quality review, half-listening to a sterilization log discussion, when my phone buzzed with an ISRG price alert. The stock had dropped sharply in pre-market trading. My first thought wasn't about my retirement account. It was: what are hospitals going to ask me today?
When the stock goes down, the questions go up. That is not a theory—it's a pattern I've seen across six years in medical device quality. Journalists write speculative pieces. Investors start digging through FDA databases. And hospital procurement teams, already nervous about the device recall coverage they read at night, suddenly want more documentation than they asked for in the previous five years combined.
I'm a quality compliance reviewer at Intuitive Surgical. I sit in the unglamorous middle ground between engineering, regulatory affairs, and the hospitals that buy our da Vinci systems. I don't design robots. I verify that everything around the robot—sterilization records, software traceability, training files, service logs—holds together when someone asks hard questions.
It Started with a Price Alert
That morning in August triggered a chain of events that changed how I think about prevention. Let me walk you through it.
The ISRG dip was real—the stock took a visible hit on market worries that I can't fully summarize here without getting into territory I'm not qualified to comment on. What I can comment on is what it did to our inbound requests. Within 48 hours, we had received eleven documentation requests from hospitals reviewing their vendor relationships. Eleven. In a normal month, we get maybe four.
One request stood out. A major health system in the Midwest—I won't name them—sent a procurement package that included their vendor quality scorecard. Forty-seven line items. It covered everything from sterilization batch traceability to field service response SLAs to software vulnerability reporting. Reading it felt like being audited by someone who had been burned before.
They had been. As it turned out, their respiratory therapy department was still recovering from the CPAP machine recall that had upended the industry a few years back. Clinics scrambling for alternatives. Patients searching for compatible equipment. Procurement teams permanently scarred by the experience.
"We evaluated a high flow nasal cannula supplier two years ago," their supply-chain director told me during a site visit. "The clinical team loved the product. The unit price was competitive. But we didn't dig deep enough into their sub-component sourcing. When their upstream supplier changed a valve material without notifying anyone, our patients noticed. Our nurses noticed. We had to switch mid-contract."
I wrote down that phrase: we had to switch mid-contract. That's the true cost of skipping prevention. It's not a line item on an invoice. It's a disruption that reaches patients.
Dips, Rumors, and a Name I Didn't Recognize
Meanwhile, the internet was doing what the internet does during a stock dip. There were threads about Intuitive Surgical's fundamentals, about procedure volume growth, about whether the da Vinci 5 upgrade cycle was on track. I know that world. It comes with the territory of being a publicly traded medical device maker.
And then there was a thread about a patient named Elizabeth. The headline framed it as "Elizabeth vs Intuitive Surgical," though the details were murky—the post had been reshared so many times over the years that it had taken on a life of its own.
I read the thread carefully. I checked our adverse event database. I asked our regulatory affairs team to verify the details. We found nothing matching that description—not a case, not a complaint, not a near-miss. It might have been a misremembered legal case from a different jurisdiction, or a mix-up with a different device manufacturer, or just someone's attempt to write a scary story during a week when scary stories got clicks. I honestly don't know.
The most frustrating part: the same week we were proving our quality systems to a hospital, strangers were confidently repeating claims that had zero basis in our records. You'd think written documentation would be enough, but misinformation travels faster than verification.
What I do know is this: the best response to an unverified claim is verification. Not defensiveness. Not silence. You check the records. You confirm the facts. And then you respond with the quiet confidence of someone who has the data. That's prevention applied to communication—the check before the claim, the documentation before the debate.
The Question Nobody Expected
The turning point came during a demo day at the health system's surgical center. They had assembled a team that included their chief of surgery, the operating room director, the supply-chain director, and an anesthesiologist who had a reputation for asking questions no one could answer.
We walked them through the da Vinci 5. We covered instrument articulation, wristed instrumentation, 3D visualization, the new force feedback features. The usual. But about forty minutes in, the anesthesiologist raised her hand and asked something that stopped the room:
"What is fluoroscopy, exactly, and how do you verify that the integration is working correctly?"
I could see our clinical sales specialist hesitate. It wasn't a product question. It was a quality question wearing different clothes. She wanted to know, at a systems level, how we ensure that the imaging layer—real-time X-ray used during procedures—stays synchronized with the robot's positioning data.
I stepped in. Fluoroscopy, I explained, is an imaging technique that uses a continuous X-ray beam to capture real-time motion—think of it like a live X-ray movie. In surgical settings, it's used to guide instruments through complex anatomy. For a robotic platform, the integration question is critical: if the imaging feed drifts relative to the robot's coordinate system, the surgeon could be looking at outdated visual information.
Then I walked her through our verification protocol. Every system that includes fluoroscopy functionality goes through an alignment test during installation. That test is documented. Calibration is re-verified during every scheduled maintenance visit, and the results are logged in a service history that is traceable to the individual system serial number. If a hospital wants to see the log, we show them the log. If they want to audit the verification process, we have an internal audit trail that goes back years.
The anesthesiologist nodded. She didn't say much. But I saw her write something on her notepad.
The 47-Point Scorecard
The next week, their supply-chain director sent me their completed version of the vendor scorecard. It was a dense spreadsheet—the kind of document that makes your eyes water if you look at it before coffee. Forty-seven criteria, each scored on a scale of one to five, with a column for comments.
I won't lie: we lost points on price. We're not the cheapest option, and we never will be. To be fair, competitors to Intuitive Surgical in the surgical robotics space have made meaningful strides, and some are aggressive on cost. I don't need to name them. You know who they are.
But price wasn't the deciding factor. They chose us. When I asked why, the supply-chain director sent me a message that I've kept, because it validates everything I believe about prevention:
"Your team was the only one that brought documentation we didn't know to ask for. The verification records. The training traceability. The risk assessment framework you follow under ISO 14971. We didn't have to chase you for it. It was already organized and ready. After the CPAP machine recall, that's what we value most."
That's the moment the penny dropped for me. This wasn't a story about sales. It was a story about prevention as a competitive advantage.
Prevention Is a Document, Not a Habit
For years, I had thought about prevention as a habit—something you build through discipline and repetition. Check twice. Verify before you approve. Follow the checklist. All true, but all incomplete.
What the scorecard taught me is that prevention is also a document. It's the quality inspection record that anticipates a question before anyone thinks to ask it. It's the service log that goes back seven years without a gap. It's the training file that proves a surgeon completed certification before their first solo case.
Here's how I've changed my own processes since that week:
- I build documentation for the question that doesn't exist yet. If I can't produce a verification record for a component within an hour, that component doesn't ship.
- I treat every stock dip like a warning. When the price moves, the scrutiny follows. My job is to have the files organized before the questions arrive. I prepare for the worst-case audit every quarter, not because I expect it, but because the preparation itself reveals gaps.
- I share the documents before being asked. The hospitals that trust us are not the ones we've wined and dined. They're the ones we've handed a complete engineering folder during a site visit, unprompted.
Five minutes of verification beats five days of correction. That's what I believed when I started this job. Now I know something deeper: the value of verification isn't just in the act—it's in being able to show someone the evidence.
When I look back at that August morning, watching the ISRG ticker drop on my phone, I remember the feeling of being defensive. I'd like to say I stopped feeling that way. I haven't entirely. But now, when the questions come—whether it's a claim from a stranger on the internet or a 47-line scoring sheet from a hospital that has been scarred by a CPAP machine recall—I reach for a folder instead of an argument.
Prevention doesn't eliminate hard questions. It just makes them easier to answer.